GAIA
Welcome,         Profile    Billing    Logout  
 2 Trials 
16 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Schröder, Johanna
FELYCIA, NCT06237166: Evaluation of an Online Intervention for Female Sexual Dysfunction

Recruiting
N/A
250
Europe
mylovia
Gaia AG, Medical School Hamburg
Female Sexual Dysfunction
05/25
05/25
InvidiCO, NCT06251518: Investigating the Effectiveness of Vimida

Recruiting
N/A
160
Europe
vimida
Gaia AG, Medical School Hamburg, Institut Long-Covid Rostock
Long COVID, Post COVID-19 Condition
07/25
07/25
Klein, Jan Philipp
REVALDI-BPD, NCT06601907: Researching the Effectiveness of a Alivis, a Digital Health Application for Borderline Personality Disorder

Recruiting
N/A
470
Europe
alivis
Gaia AG, Zentrum für Integrative Psychiatrie
Borderline Personality Disorder (BPD)
09/26
09/26
Jacob, Gitta
NCT05529797: Effect of a Single Virtual Reality Exposure on Depressive Symptoms (Veovita-VR)

Completed
N/A
128
Europe
Veovita-VR
Gaia AG
Depression
05/23
05/23
EU-OPTMi, NCT04276142: Effectiveness of a Dialogue-based Online Intervention Against Migraine

Completed
N/A
321
Europe
ceprica (additional to treatment as usual), active control intervention (additional to treatment as usual)
Gaia AG
Migraine
08/24
08/24
OnSeT-2D, NCT05525117: Effectiveness of an Online Self-management Intervention for Type 2 Diabetes Mellitus

Withdrawn
N/A
268
Europe
covivio (additional to treatment as usual), treatment as usual
Gaia AG
Type 2 Diabetes
07/24
12/24
APRICOT, NCT06221956: Effectiveness of a Digital Health Application for Subacute and Chronic Back Pain (Relevis)

Recruiting
N/A
276
Europe
relevis
Gaia AG, University Hospital Schleswig-Holstein, Philipps Universität Marburg
Back Pain
01/25
01/25
READ-ADHD, NCT06221930: Researching the Effectiveness of Attexis, a Digital Health Application for Adults With Attention Deficit Hyperactivity Disorder

Active, not recruiting
N/A
337
Europe
attexis
Gaia AG, Zentrum für Integrative Psychiatrie Kiel, University Hospital, Saarland
Adult Attention Deficit Hyperactivity Disorder
09/24
03/25
NCT06243978: Effectiveness of a Digital Health Application for Primary Hypertension (Liebria)

Recruiting
N/A
328
Europe
liebria, information brochure on hypertension
Gaia AG, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Charite University, Berlin, Germany
Hypertension
04/25
04/25
NCT05998161: Evaluating the Effectiveness of a Digital Therapeutic (Reviga) for People With Stress or Burnout

Completed
N/A
295
Europe
reviga
Gaia AG, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Hannover Medical School
Stress, Burnout
06/24
06/24
FELYCIA, NCT06237166: Evaluation of an Online Intervention for Female Sexual Dysfunction

Recruiting
N/A
250
Europe
mylovia
Gaia AG, Medical School Hamburg
Female Sexual Dysfunction
05/25
05/25
NCT06027034: Effectiveness of a Digital Health Application for Psoriasis

Recruiting
N/A
348
Europe
Online program for psoriasis (GAIA-PSO-01)
Gaia AG, University of Giessen, Universitätsklinikum Hamburg-Eppendorf
Psoriasis
06/25
06/25
InvidiCO, NCT06251518: Investigating the Effectiveness of Vimida

Recruiting
N/A
160
Europe
vimida
Gaia AG, Medical School Hamburg, Institut Long-Covid Rostock
Long COVID, Post COVID-19 Condition
07/25
07/25
REVALDI-BPD, NCT06601907: Researching the Effectiveness of a Alivis, a Digital Health Application for Borderline Personality Disorder

Recruiting
N/A
470
Europe
alivis
Gaia AG, Zentrum für Integrative Psychiatrie
Borderline Personality Disorder (BPD)
09/26
09/26
EASE-T2DM, NCT06529965: Evaluating a Digital Intervention for Alleviating Diabetes-specific Emotional Distress in Adults Living With T2DM

Recruiting
N/A
250
Europe
covivio
Gaia AG, University Hospital Schleswig-Holstein, Philipps University Marburg Medical Center
Glucose Metabolism Disorders (Including Diabetes Mellitus), Metabolic Disease, Endocrine System Diseases, Diabetes Mellitus, Type 2
04/26
04/26
LAMONT, NCT06090305: Effectiveness of a Digital Health Application for Multiple Sclerosis (Levidex)

Recruiting
N/A
470
Europe
levidex, Control, treatment as usual (TAU)
Gaia AG, University Hospital Schleswig-Holstein, Universität Duisburg-Essen
Multiple Sclerosis
10/24
10/24

Download Options